A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.

Schennach-Wolff, R; Möller, H-J; Jäger, M; Seemüller, F; Obermeier, M; Messer, T; Laux, G; Pfeiffer, H; Naber, D; Schmidt, L G; Gaebel, W; Klosterkötter, J; Heuser, I; Maier, W; Lemke, M R; Rüther, E; Klingberg, S; Gastpar, M; Riedel, M

Schennach-Wolff, R; Möller, H-J; Jäger, M; Seemüller, F; Obermeier, M; Messer, T; Laux, G; Pfeiffer, H; Naber, D; Schmidt, L G; Gaebel, W; Klosterkötter, J; Heuser, I; Maier, W; Lemke, M R; Rüther, E; Klingberg, S; Gastpar, M; Riedel, M.

Affiliation

Schennach-Wolff R; Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich, Germany. Rebecca.Schennach-Wolff@med.uni-muenchen.de

Pharmacopsychiatry ; 43(7): 245-51, 2010 Nov.

Article in En | MEDLINE | ID: mdl-20927697

Subject(s)

Antipsychotic Agents/therapeutic use; Clinical Trials as Topic; Patient Selection; Schizophrenia/diagnosis; Schizophrenia/drug therapy; Adult; Consensus; Consensus Development Conferences as Topic; Female; Hospitalization; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenic Psychology; Severity of Illness Index; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Clinical Trials as Topic / Patient Selection Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Pharmacopsychiatry Year: 2010 Document type: Article

Fulltext

XML

PubMed Links

Search on Google